Tag: biomedical
-
Start-Up to Engineer T-Cells for Autoimmune Diseases
GentiBio Inc., a new enterprise in Boston, is starting work on creating engineered T-cells from the immune system to treat autoimmune diseases.
-
Venture Fund Plans $350M for Biotech Start-Ups
A new venture fund plans investments in early-stage life science companies addressing critical needs in therapeutics, but also agriculture and industrial biotechnology.
-
NIH Begins Covid-19 Antibody Trials
National Institutes of Health is beginning clinical trials of experimental antibody therapies to treat Covid-19 infections in people with symptoms ranging from mild to severe.
-
UCLA, Apple Partner on Depression Study
Researchers from University of California in Los Angeles and Apple Corp. are beginning a study of wearable and home technologies to detect depression.
-
New Allergy Biotech Launches, Raises $10M
A new company developing treatments to relieve allergic reactions with reprogrammed antibodies began work and is raising $10 million in its first venture funding round.
-
Trial Set for Covid-19 Antibodies in Long-Term Care
Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 infections among people in long-term care.
-
Covid-19 Vaccines, Therapies – 3 August 2020
The numbers of vaccine candidates in development and clinical trials show modest but steady growth, now up to 157 and 35 respectively.
-
NIH Issues Contracts for Faster Covid-19 Diagnostics
National Institutes of Health awarded contracts to seven companies for higher-speed Covid-19 detection tests to ease current reporting delays.
-
A.I. Employed for Local Covid-19 Prediction Models
Computer scientists in California are writing deep learning algorithms that generate forecasts for Covid-19 infections in local communities.
-
Two Covid-19 Vaccines Show Preclinical Immune Responses
Two candidate vaccines to prevent Covid-19 infections show they generate immune protections in lab monkeys, with one vaccine for 13 weeks.